Turkey Company Roundup: Baxter Rejigs JV, Sanofi Mulls Insulin Plant
This article was originally published in PharmAsia News
Executive Summary
Following its spin-off from Baxter, Baxalta has formed a new partnership with a leading Turkish firm, while Sanofi Turkey is considering the local manufacture of an insulin product. Elsewhere, senior management changes have taken place at GSK and Bayer.